In the Spring of my first year, we worked together with Advanced Animal Diagnostics to help them understand how they could use their leukocyte differential technology in humans.
We researched market opportunities and conducted a Voice of Customer campaign to capture their ideas on a point-of-care test for sepsis.
The COVID-19 pandemic occurred mid project and it highlighted the importance of their technology in clinical settings.